Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Novo Integrated Sciences ( (NVOS) ).
Novo Integrated Sciences and the Successor Receiver have terminated their $60 million deal involving the Ophir Collection, a set of valuable gemstones. The agreement was initially approved by the court, allowing the receiver to sell the collection to Novo, who had already made a non-refundable deposit of $230,000. This development might impact stakeholders interested in the financial maneuvers surrounding high-value asset acquisitions.
See more insights into NVOS stock on TipRanks’ Stock Analysis page.